Furthermore, after treatment using Bortezomib, MM cell adhesion to bone marrow stromal cells has been noted to lead to IL-6 secretion, subsequently leading to the activation of NFκB within these stromal cells31. Here, NFKB1 is linked to Miyoshi myopathy.